The miR-200 and miR-221/222 microRNA families: opposing effects on epithelial identity
- PMID: 22350980
- PMCID: PMC4561555
- DOI: 10.1007/s10911-012-9244-6
The miR-200 and miR-221/222 microRNA families: opposing effects on epithelial identity
Abstract
Carcinogenesis is a complex process during which cells undergo genetic and epigenetic alterations. These changes can lead tumor cells to acquire characteristics that enable movement from the primary site of origin when conditions become unfavorable. Such characteristics include gain of front-rear polarity, increased migration/invasion, and resistance to anoikis, which facilitate tumor survival during metastasis. An epithelial to mesenchymal transition (EMT) constitutes one way that cancer cells can gain traits that promote tumor progression and metastasis. Two microRNA (miRNA) families, the miR-200 and miR-221 families, play crucial opposing roles that affect the differentiation state of breast cancers. These two families are differentially expressed between the luminal A subtype of breast cancer as compared to the less well-differentiated triple negative breast cancers (TNBCs) that exhibit markers indicative of an EMT. The miR-200 family promotes a well-differentiated epithelial phenotype, while high miR-221/222 results in a poorly differentiated, mesenchymal-like phenotype. This review focuses on the mechanisms (specific proven targets) by which these two miRNA families exert opposing effects on cellular plasticity during breast tumorigenesis and metastasis.
Figures




Similar articles
-
TWIST1-Induced miR-424 Reversibly Drives Mesenchymal Programming while Inhibiting Tumor Initiation.Cancer Res. 2015 May 1;75(9):1908-21. doi: 10.1158/0008-5472.CAN-14-2394. Epub 2015 Feb 25. Cancer Res. 2015. PMID: 25716682 Free PMC article.
-
Elucidating the Role of MicroRNA-18a in Propelling a Hybrid Epithelial-Mesenchymal Phenotype and Driving Malignant Progression in ER-Negative Breast Cancer.Cells. 2024 May 10;13(10):821. doi: 10.3390/cells13100821. Cells. 2024. PMID: 38786043 Free PMC article.
-
Targets of miR-200c mediate suppression of cell motility and anoikis resistance.Breast Cancer Res. 2011 Apr 18;13(2):R45. doi: 10.1186/bcr2867. Breast Cancer Res. 2011. PMID: 21501518 Free PMC article.
-
ERα, microRNAs, and the epithelial-mesenchymal transition in breast cancer.Trends Endocrinol Metab. 2012 Feb;23(2):73-82. doi: 10.1016/j.tem.2011.12.001. Epub 2012 Jan 16. Trends Endocrinol Metab. 2012. PMID: 22257677 Review.
-
A step-by-step microRNA guide to cancer development and metastasis.Cell Oncol (Dordr). 2017 Aug;40(4):303-339. doi: 10.1007/s13402-017-0341-9. Epub 2017 Jul 26. Cell Oncol (Dordr). 2017. PMID: 28748501 Review.
Cited by
-
Changes in miR-221/222 Levels in Invasive and In Situ Carcinomas of the Breast: Differences in Association with Estrogen Receptor and TIMP3 Expression Levels.Mol Diagn Ther. 2016 Dec;20(6):603-615. doi: 10.1007/s40291-016-0230-3. Mol Diagn Ther. 2016. PMID: 27488105
-
MicroRNA-222-3p/GNAI2/AKT axis inhibits epithelial ovarian cancer cell growth and associates with good overall survival.Oncotarget. 2016 Dec 6;7(49):80633-80654. doi: 10.18632/oncotarget.13017. Oncotarget. 2016. PMID: 27811362 Free PMC article.
-
Non-Coding RNAs as New Therapeutic Targets in the Context of Renal Fibrosis.Int J Mol Sci. 2019 Apr 23;20(8):1977. doi: 10.3390/ijms20081977. Int J Mol Sci. 2019. PMID: 31018516 Free PMC article. Review.
-
Bioinformatics identification of dysregulated microRNAs in triple negative breast cancer based on microRNA expression profiling.Oncol Lett. 2018 Mar;15(3):3017-3023. doi: 10.3892/ol.2017.7707. Epub 2017 Dec 28. Oncol Lett. 2018. PMID: 29435032 Free PMC article.
-
The Current Treatment Paradigm for Pancreatic Ductal Adenocarcinoma and Barriers to Therapeutic Efficacy.Front Oncol. 2021 Jul 15;11:688377. doi: 10.3389/fonc.2021.688377. eCollection 2021. Front Oncol. 2021. PMID: 34336673 Free PMC article. Review.
References
-
- Pillai RS, Bhattacharyya SN, Filipowicz W. Repression of protein synthesis by miRNAs: how many mechanisms? Trends in Cell Biology. 2007 Mar;17(3):118–126. - PubMed
-
- Stefani G, Slack FJ. Small non-coding RNAs in animal development. Nature Reviews. Molecular Cell Biology. 2008 Mar;9(3):219–230. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical